| Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead WH Goodson III, L Lowe, DO Carpenter, M Gilbertson, A Manaf Ali, ... Carcinogenesis 36 (Suppl_1), S254-S296, 2015 | 365 | 2015 |
| Concise review: neutral endopeptidase (CD10): a multifaceted environment actor in stem cells, physiological mechanisms, and cancer V Maguer-Satta, R Besançon, E Bachelard-Cascales Stem cells 29 (3), 389-396, 2011 | 240 | 2011 |
| Regulation of human erythropoiesis by activin A, BMP2, and BMP4, members of the TGFβ family V éronique Maguer-Satta, L Bartholin, S Jeanpierre, M Ffrench, S Martel, ... Experimental cell research 282 (2), 110-120, 2003 | 181 | 2003 |
| The current paradigm and challenges ahead for the dormancy of disseminated tumor cells E Risson, AR Nobre, V Maguer-Satta, JA Aguirre-Ghiso Nature Cancer 1 (7), 672-680, 2020 | 180 | 2020 |
| The effect of environmental chemicals on the tumor microenvironment SC Casey, M Vaccari, F Al-Mulla, R Al-Temaimi, A Amedei, ... Carcinogenesis 36 (Suppl_1), S160-S183, 2015 | 144 | 2015 |
| Transcription activation of FLRG and follistatin by activin A, through Smad proteins, participates in a negative feedback loop to modulate activin A function L Bartholin, V Maguer-Satta, S Hayette, S Martel, M Gadoux, L Corbo, ... Oncogene 21 (14), 2227-2235, 2002 | 116 | 2002 |
| The CD10 enzyme is a key player to identify and regulate human mammary stem cells E Bachelard-Cascales, M Chapellier, E Delay, G Pochon, T Voeltzel, ... Stem cells 28 (6), 1081-1088, 2010 | 110 | 2010 |
| Targeting BCR-ABL-independent TKI resistance in chronic myeloid leukemia by mTOR and autophagy inhibition R Mitchell, LEM Hopcroft, P Baquero, EK Allan, K Hewit, D James, ... JNCI: Journal of the National Cancer Institute 110 (5), 467-478, 2018 | 104 | 2018 |
| FLRG, member of the follistatin family, a new player in hematopoiesis V Maguer-Satta, R Rimokh Molecular and cellular endocrinology 225 (1-2), 109-118, 2004 | 99 | 2004 |
| Primitive CML cell expansion relies on abnormal levels of BMPs provided by the niche and on BMPRIb overexpression B Laperrousaz, S Jeanpierre, K Sagorny, T Voeltzel, S Ramas, ... Blood, The Journal of the American Society of Hematology 122 (23), 3767-3777, 2013 | 97 | 2013 |
| The BCR-ABLT315I mutation compromises survival in chronic phase chronic myelogenous leukemia patients resistant to tyrosine kinase inhibitors, in a matched pair analysis FE Nicolini, AR Ibrahim, S Soverini, G Martinelli, MC Müller, A Hochhaus, ... Haematologica 98 (10), 1510, 2013 | 85 | 2013 |
| A novel role for fibronectin type I domain in the regulation of human hematopoietic cell adhesiveness through binding to follistatin domains of FLRG and follistatin V Maguer-Satta, S Forissier, L Bartholin, S Martel, S Jeanpierre, ... Experimental cell research 312 (4), 434-442, 2006 | 84 | 2006 |
| Cancer stem cells: the emerging challenge of drug targeting R Besançon, S Valsesia-Wittmann, A Puisieux, CC de Fromentel, ... Current medicinal chemistry 16 (4), 394-416, 2009 | 82 | 2009 |
| BMP4 regulation of human megakaryocytic differentiation is involved in thrombopoietin signaling S Jeanpierre, FE Nicolini, B Kaniewski, C Dumontet, R Rimokh, ... Blood, The Journal of the American Society of Hematology 112 (8), 3154-3163, 2008 | 81 | 2008 |
| The BMI1 polycomb protein represses cyclin G2-induced autophagy to support proliferation in chronic myeloid leukemia cells L Mourgues, V Imbert, M Nebout, P Colosetti, Z Neffati, P Lagadec, ... Leukemia 29 (10), 1993-2002, 2015 | 67 | 2015 |
| Disequilibrium of BMP2 levels in the breast stem cell niche launches epithelial transformation by overamplifying BMPR1B cell response M Chapellier, E Bachelard-Cascales, X Schmidt, F Clément, I Treilleux, ... Stem cell reports 4 (2), 239-254, 2015 | 67 | 2015 |
| Deregulation of TWIST-1 in the CD34+ compartment represents a novel prognostic factor in chronic myeloid leukemia E Cosset, G Hamdan, S Jeanpierre, T Voeltzel, K Sagorny, S Hayette, ... Blood, The Journal of the American Society of Hematology 117 (5), 1673-1676, 2011 | 66 | 2011 |
| BCR-ABL expression in different subpopulations of functionally characterized Ph+ CD34+ cells from patients with chronic myeloid leukemia V Maguer-Satta, AL Petzer, AC Eaves, CJ Eaves | 65 | 1996 |
| Nilotinib and peginterferon alfa-2a for newly diagnosed chronic-phase chronic myeloid leukaemia (NiloPeg): a multicentre, non-randomised, open-label phase 2 study FE Nicolini, G Etienne, V Dubruille, L Roy, F Huguet, L Legros, ... The Lancet Haematology 2 (1), e37-e46, 2015 | 64 | 2015 |
| BCR–ABL accelerates C2-ceramide-induced apoptosis V Maguer-Satta, S Burl, L Liu, J Damen, H Chahine, G Krystal, A Eaves, ... Oncogene 16 (2), 237-248, 1998 | 62 | 1998 |